SBSB
Sullivan, Bruyette, Speros & Blaney Portfolio holdings
AUM
$2.27B
This Quarter Return
+18.15%
1 Year Return
+50.71%
3 Year Return
+46.71%
5 Year Return
+86.96%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(+15%)
Cap. Flow
-$24.8M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
74.78%
Holding
338
New
41
Increased
100
Reduced
105
Closed
12
Top Buys
| 1 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
$5.09M |
| 2 |
iShares Gold Trust
IAU
|
$4.54M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.49M |
| 4 |
Vanguard Extended Market ETF
VXF
|
$2.06M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
$1.97M |
Top Sells
| 1 |
Vanguard Total Bond Market
BND
|
$29.8M |
| 2 |
Schwab International Equity ETF
SCHF
|
$4.95M |
| 3 |
Vanguard Large-Cap ETF
VV
|
$4.29M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$3.42M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$3.3M |
Sector Composition
| 1 | Technology | 4.64% |
| 2 | Healthcare | 2.07% |
| 3 | Financials | 1.14% |
| 4 | Consumer Discretionary | 0.97% |
| 5 | Consumer Staples | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Altria Group
MO
$113B
| $212K | 0.01% |
5,394
-373
| -6% | -$14.7K |
|
227
Linde
LIN
$224B
| $211K | 0.01% |
993
+116
| +13% | +$24.6K |
|
228
Edwards Lifesciences
EW
$47.8B
| $209K | 0.01% |
3,021
+2,014
| +200% | +$139K |
|
229
Fiserv
FI
$75.1B
| $209K | 0.01% |
2,138
+520
| +32% | +$50.8K |
|
230
Schwab US Large- Cap ETF
SCHX
$59B
| $207K | 0.01% |
2,797
+1
| +0% | +$74 |
|
231
Equifax
EFX
$30.3B
| $206K | 0.01% |
1,200
| – | – |
|
232
Corning
GLW
$57.4B
| $206K | 0.01% |
+7,972
| New | +$206K |
|
233
DuPont de Nemours
DD
$32.2B
| $205K | 0.01% |
3,859
-119
| -3% | -$6.32K |
|
234
iShares US Consumer Discretionary ETF
IYC
$1.72B
| $204K | 0.01% |
932
| – | – |
|
235
Rockwell Automation
ROK
$38.6B
| $204K | 0.01% |
957
| – | – |
|
236
Becton Dickinson
BDX
$55.3B
| $202K | 0.01% |
843
-40
| -5% | -$9.59K |
|
237
SAP
SAP
$317B
| $200K | 0.01% |
1,429
| – | – |
|
238
W.P. Carey
WPC
$14.7B
| $199K | 0.01% |
2,938
| – | – |
|
239
Dow Inc
DOW
$17.5B
| $198K | 0.01% |
4,859
+429
| +10% | +$17.5K |
|
240
iShares MSCI Emerging Markets ETF
EEM
$19B
| $197K | 0.01% |
4,926
-34
| -0.7% | -$1.36K |
|
241
DexCom
DXCM
$29.5B
| $195K | 0.01% |
482
+56
| +13% | +$22.7K |
|
242
McKesson
MCK
$85.4B
| $194K | 0.01% |
1,266
+2
| +0.2% | +$306 |
|
|
XIFR
243
XPLR Infrastructure, LP
XIFR
$996M
| $194K | 0.01% |
+3,775
| New | +$194K |
|
244
Broadridge
BR
$29.9B
| $189K | 0.01% |
+1,496
| New | +$189K |
|
|
WBA
245
DELISTED
Walgreens Boots Alliance
WBA
| $189K | 0.01% |
4,447
| – | – |
|
246
Intuitive Surgical
ISRG
$170B
| $188K | 0.01% |
330
+3
| +0.9% | +$1.71K |
|
247
iShares Morningstar Mid-Cap Value ETF
IMCV
$828M
| $184K | 0.01% |
1,454
| – | – |
|
248
Nuveen Municipal Credit Income Fund
NZF
$2.32B
| $184K | 0.01% |
12,449
-299
| -2% | -$4.42K |
|
|
ETV
249
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.63B
| $181K | 0.01% |
12,812
| – | – |
|
250
Elevance Health
ELV
$71.8B
| $178K | 0.01% |
677
| – | – |
|